Considering that the CRC patients had higher serum CGRP levels than the control group, and considering the association between high levels of CGRP in CRC patients’ serum and advanced stages and decreased survival rate, we can say that it can be used both as a diagnostic and prognostic marker in patients with colorectal cancer. This evidence concerns the gene CALCA and colorectal carcinoma.